Balance Sheet Neuronetics, Inc.

Equities

STIM

US64131A1051

Advanced Medical Equipment & Technology

Market Closed - Nasdaq Other stock markets 21:00:00 11/05/2026 BST			5-day change	1st Jan Change
1.505 ^USD	-9.06%		-25.50%	+9.06%

05-05	Neuronetics, Inc., Q1 2026 Earnings Call, May 05, 2026
05-05	Neuronetics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI

bf370a192876.S_4UVFIOm2JUOhEyK1j5UZPSe6f6rzfmSHbDCSwkLA0.IbktJ2A70BQVXFttbxC8FdalCdGoxH2veDmcTxRxVUsYy1gnFmjiIDNVXA

Published financial data: NEURONETICS, INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	55.31M	65.21M	71.35M	74.89M	149M
Total Revenues	55.31M	65.21M	71.35M	74.89M	149M
Cost of Goods Sold, Total	11.65M	15.48M	17.74M	20.13M	76.45M
Gross Profit	43.66M	49.72M	53.6M	54.76M	72.71M
Selling General & Admin Expenses, Total	62.8M	74.9M	72.64M	75.95M	97.16M
R&D Expenses	7.92M	9.34M	9.52M	12.77M	6.58M
Other Operating Expenses, Total	70.72M	84.23M	82.16M	88.72M	104M
Operating Income	-27.06M	-34.51M	-28.55M	-33.96M	-31.04M
Interest Expense, Total	-4.02M	-4.25M	-5.42M	-7.29M	-8.42M
Interest And Investment Income	390K	2.2M	600K	2.55M	716K
Net Interest Expenses	-3.63M	-2.05M	-4.82M	-4.74M	-7.7M
Other Non Operating Income (Expenses)	-	-	2.29M	-	-
EBT, Excl. Unusual Items	-30.69M	-36.56M	-31.09M	-38.7M	-38.74M
Asset Writedown	-	-	-2M	-600K	-400K
Other Unusual Items	-500K	-600K	2.9M	-4.43M	-
EBT, Incl. Unusual Items	-31.19M	-37.16M	-30.19M	-43.73M	-39.14M
Earnings From Continuing Operations	-31.19M	-37.16M	-30.19M	-43.73M	-39.14M
Net Income to Company	-31.19M	-37.16M	-30.19M	-43.73M	-39.14M
Minority Interest	-	-	-	19K	137K
Net Income - (IS)	-31.19M	-37.16M	-30.19M	-43.71M	-39M
Net Income to Common Incl Extra Items	-31.19M	-37.16M	-30.19M	-43.71M	-39M
Net Income to Common Excl. Extra Items	-31.19M	-37.16M	-30.19M	-43.71M	-39M
Per Share Items
Net EPS - Basic	-1.22	-1.38	-1.05	-1.38	-0.59
Basic EPS - Continuing Operations	-1.22	-1.38	-1.05	-1.38	-0.59
Basic Weighted Average Shares Outstanding	25.48M	26.9M	28.66M	31.73M	65.95M
Net EPS - Diluted	-1.22	-1.38	-1.05	-1.38	-0.59
Diluted EPS - Continuing Operations	-1.22	-1.38	-1.05	-1.38	-0.59
Diluted Weighted Average Shares Outstanding	25.48M	26.9M	28.66M	31.73M	65.95M
Normalized Basic EPS	-0.75	-0.85	-0.68	-0.76	-0.37
Normalized Diluted EPS	-0.75	-0.85	-0.68	-0.76	-0.37
Supplemental Items
EBITDA	-26M	-32.86M	-26.64M	-31.98M	-27.63M
EBITA	-27.06M	-34.51M	-28.55M	-33.96M	-31.04M
EBIT	-27.06M	-34.51M	-28.55M	-33.96M	-31.04M
EBITDAR	-25.3M	-32.06M	-25.84M	-30.98M	-18.13M
Total Revenues (As Reported)	-	-	-	-	149M
Normalized Net Income	-19.18M	-22.85M	-19.43M	-24.17M	-24.07M
Interest on Long-Term Debt	4.02M	4.25M	5.42M	7.29M	8.42M
Supplemental Operating Expense Items
Selling and Marketing Expenses	37.75M	49.98M	47.22M	45.63M	47.46M
General and Administrative Expenses	25.05M	24.92M	25.43M	30.32M	49.7M
Research And Development Expense From Footnotes	7.92M	9.34M	9.52M	12.77M	6.58M
Net Rental Expense, Total	700K	800K	800K	1M	9.5M
Imputed Operating Lease Interest Expense	578K	686K	679K	803K	7.4M
Imputed Operating Lease Depreciation	122K	114K	121K	197K	2.1M
Stock-Based Comp., COGS (Total)	79K	130K	140K	140K	108K
Stock-Based Comp., R&D Exp. (Total)	198K	462K	677K	644K	664K
Stock-Based Comp., S&M Exp. (Total)	2.1M	4.29M	2.33M	1.41M	1.18M
Stock-Based Comp., G&A Exp. (Total)	5.5M	3.87M	4.17M	3.41M	4.9M
Total Stock-Based Compensation	7.87M	8.75M	7.32M	5.6M	6.85M

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	94.14M	70.34M	59.68M	18.46M	28.13M
Total Cash And Short Term Investments	94.14M	70.34M	59.68M	18.46M	28.13M
Accounts Receivable, Total	9.9M	15.13M	16.69M	23.56M	16.69M
Other Receivables	-	-	2.9M	2.9M	-
Notes Receivable	74K	230K	2.06M	930K	424K
Total Receivables	9.98M	15.36M	21.64M	27.39M	17.12M
Inventory	6.56M	8.9M	8.09M	4.25M	4.33M
Prepaid Expenses	3.09M	2.17M	1.87M	3.95M	2.92M
Restricted Cash	-	-	-	1M	6M
Other Current Assets, Total	1.56M	2M	2.51M	3.08M	3.05M
Total Current Assets	115M	98.77M	93.79M	58.12M	61.55M
Gross Property Plant And Equipment	7.64M	8.38M	7.6M	36.58M	32.08M
Accumulated Depreciation	-2.54M	-3.06M	-2.82M	-3.24M	-4.05M
Net Property Plant And Equipment	5.1M	5.32M	4.78M	33.34M	28.03M
Goodwill	-	-	-	18.63M	23.62M
Other Intangibles, Total	-	3.6M	4.2M	20.01M	18.95M
Accounts Receivable Long-Term	1.7M	1.22M	661K	86K	98K
Loans Receivable Long-Term	10.11M	362K	3.8M	295K	151K
Deferred Charges Long-Term	6.76M	7.57M	8.37M	8.9M	7.97M
Other Long-Term Assets, Total	2.22M	45K	230K	1.52M	1.18M
Total Assets	141M	117M	116M	141M	142M
Liabilities
Accounts Payable, Total	4.3M	2.43M	4.75M	11.08M	10.74M
Accrued Expenses, Total	7.93M	14.51M	12.38M	12.59M	12.14M
Current Portion of Long-Term Debt	-	13.12M	-	-	-
Current Portion of Leases	670K	824K	845K	4.79M	5.56M
Unearned Revenue Current, Total	2.5M	1.98M	1.62M	974K	753K
Other Current Liabilities	306K	328K	213K	1.84M	1.33M
Total Current Liabilities	15.7M	33.2M	19.81M	31.26M	30.52M
Long-Term Debt	35.34M	22.83M	59.28M	55.15M	65.81M
Long-Term Leases	3.54M	2.97M	2.35M	22.69M	18.94M
Unearned Revenue Non Current	1.47M	829K	200K	2K	48K
Other Non Current Liabilities	-	-	-	-	-
Total Liabilities	56.05M	59.82M	81.64M	109M	115M
Preferred Stock Convertible	-	-	-	-	-
Preferred Stock - Others	-	-	-	-	-
Total Preferred Equity	-	-	-	-	-
Common Stock, Total	264K	273K	291K	557K	690K
Additional Paid In Capital	394M	403M	410M	447M	480M
Retained Earnings	-309M	-346M	-376M	-420M	-459M
Total Common Equity	85.18M	57.06M	34.19M	27.71M	22.38M
Minority Interest	-	-	-	4.09M	3.86M
Total Equity	85.18M	57.06M	34.19M	31.8M	26.24M
Total Liabilities And Equity	141M	117M	116M	141M	142M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	26.63M	28.36M	29.76M	65.81M	69.28M
ECS Total Common Shares Outstanding	26.4M	27.27M	29.09M	55.68M	68.99M
Book Value / Share	3.23	2.09	1.18	0.5	0.32
Tangible Book Value	85.18M	53.46M	29.99M	-10.93M	-20.19M
Tangible Book Value Per Share	3.23	1.96	1.03	-0.2	-0.29
Total Debt	39.54M	39.74M	62.47M	82.63M	90.3M
Net Debt	-54.6M	-30.6M	2.8M	64.17M	62.17M
Debt Equivalent Oper. Leases	5.6M	6.4M	6.4M	8M	76M
Minority Interest, Total (Incl. Fin. Div)	-	-	-	4.09M	3.86M
Account Code - Inventory Valuation	5	5	5	5	5
Machinery, Total	3.29M	3.61M	2.85M	7.28M	6.75M
Full Time Employees	175	194	203	716	658
Assets on Operating Lease - Gross	-	-	542K	598K	157K
Assets on Operating Lease - Accumulated Depreciation	-	-	-42K	-298K	-57K
Accumulated Allowance for Doubtful Accounts (Supple)	1.46M	1.65M	795K	1.93M	1.04M

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	-31.19M	-37.16M	-30.19M	-43.71M	-39M
Depreciation & Amortization - CF	1.06M	1.65M	2.01M	2.07M	3.46M
Depreciation & Amortization, Total	1.06M	1.65M	2.01M	2.07M	3.46M
(Gain) Loss From Sale Of Asset	-	-	-	28K	72K
Asset Writedown & Restructuring Costs	-	-	-	3.96M	-
Stock-Based Compensation (CF)	7.87M	8.75M	7.32M	5.6M	6.85M
Provision and Write-off of Bad Debts	-	-	390K	2.06M	587K
Other Operating Activities, Total	918K	801K	2.54M	5.8M	1.08M
Change In Accounts Receivable	-3.05M	-6.32M	-8.83M	-3.73M	3.54M
Change In Inventories	-3.44M	-2.59M	-1.1M	3.15M	-395K
Change In Accounts Payable	276K	-1.97M	2.03M	-1.98M	-1.75M
Change in Unearned Revenues	215K	-1.16M	-989K	-843K	-175K
Change in Other Net Operating Assets	-630K	7.26M	-5.21M	-3.4M	5.36M
Cash from Operations	-27.98M	-30.74M	-32.04M	-31M	-20.37M
Capital Expenditure	-2.35M	-3.27M	-2.37M	-1.47M	-801K
Cash Acquisitions	-	-	-	-2.55M	-
Other Investing Activities, Total	-7.49M	10M	1.05M	1.61M	-
Cash from Investing	-9.84M	6.73M	-1.32M	-2.41M	-801K
Long-Term Debt Issued, Total	-	-	25M	57.48M	10M
Total Debt Issued	-	-	25M	57.48M	10M
Long-Term Debt Repaid, Total	-	-	-1.2M	-60M	-211K
Total Debt Repaid	-	-	-1.2M	-60M	-211K
Issuance of Common Stock	83.41M	298K	1K	1K	29.03M
Issuance of Preferred Stock	-	-	-	-	-
Other Financing Activities, Total	-401K	-91K	-1.1M	-4.29M	-2.96M
Cash from Financing	83.01M	207K	22.7M	-6.81M	35.85M
Net Change in Cash	45.18M	-23.8M	-10.66M	-40.22M	14.68M
Supplemental Items
Cash Interest Paid	3.3M	3.54M	4.79M	6.51M	7.59M
Levered Free Cash Flow	-16.04M	-20.12M	-20.25M	-17.61M	-10.41M
Unlevered Free Cash Flow	-13.53M	-17.47M	-16.86M	-13.06M	-5.15M
Change In Net Working Capital	3.19M	3.02M	5.97M	-1.96M	-4.73M
Net Debt Issued / Repaid	-	-	23.8M	-2.52M	9.79M

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	-15.39	-16.71	-15.34	-16.54	-13.73
Return on Total Capital	-17.94	-19.47	-18.45	-20.11	-16.8
Return On Equity %	-56.37	-52.25	-66.17	-132.53	-134.86
Return on Common Equity	-56.37	-52.25	-66.17	-141.23	-155.73
Margin Analysis
Gross Profit Margin %	78.93	76.26	75.13	73.12	48.75
SG&A Margin	113.54	114.86	101.82	101.42	65.14
EBITDA Margin %	-47.01	-50.4	-37.34	-42.7	-18.52
EBITA Margin %	-48.93	-52.93	-40.02	-45.35	-20.81
EBIT Margin %	-48.93	-52.93	-40.02	-45.35	-20.81
Income From Continuing Operations Margin %	-56.39	-56.99	-42.31	-58.39	-26.24
Net Income Margin %	-56.39	-56.99	-42.31	-58.36	-26.15
Net Avail. For Common Margin %	-56.39	-56.99	-42.31	-58.36	-26.15
Normalized Net Income Margin	-34.68	-35.04	-27.23	-32.27	-16.14
Levered Free Cash Flow Margin	-29	-30.86	-28.38	-23.52	-6.98
Unlevered Free Cash Flow Margin	-24.46	-26.79	-23.63	-17.44	-3.46
Asset Turnover
Asset Turnover	0.5	0.51	0.61	0.58	1.06
Fixed Assets Turnover	11.96	12.51	14.13	3.93	4.86
Receivables Turnover (Average Receivables)	5.84	5.21	4.49	3.72	7.41
Inventory Turnover (Average Inventory)	2.27	2	2.09	3.26	17.83
Short Term Liquidity
Current Ratio	7.34	2.98	4.73	1.86	2.02
Quick Ratio	6.63	2.57	4	1.44	1.47
Operating Cash Flow to Current Liabilities	-1.78	-0.93	-1.62	-0.99	-0.67
Days Sales Outstanding (Average Receivables)	62.55	70.06	81.38	98.35	49.25
Days Outstanding Inventory (Average Inventory)	161.04	182.25	174.78	112.2	20.47
Average Days Payable Outstanding	101.32	68.95	77.42	177.89	52.03
Cash Conversion Cycle (Average Days)	122.27	183.37	178.74	32.66	17.7
Long Term Solvency
Total Debt/Equity	46.43	69.65	182.73	259.84	344.14
Total Debt / Total Capital	31.71	41.06	64.63	72.21	77.48
LT Debt/Equity	45.64	45.21	180.25	244.78	322.95
Long-Term Debt / Total Capital	31.17	26.65	63.76	68.02	72.71
Total Liabilities / Total Assets	39.69	51.18	70.48	77.43	81.46
EBIT / Interest Expense	-6.73	-8.12	-5.26	-4.66	-3.69
EBITDA / Interest Expense	-6.3	-7.54	-4.76	-4.25	-2.15
(EBITDA - Capex) / Interest Expense	-6.88	-8.31	-5.2	-4.45	-2.25
Total Debt / EBITDA	-1.56	-1.24	-2.42	-2.67	-4.98
Net Debt / EBITDA	2.16	0.95	-0.11	-2.07	-3.43
Total Debt / (EBITDA - Capex)	-1.43	-1.12	-2.21	-2.55	-4.77
Net Debt / (EBITDA - Capex)	1.97	0.87	-0.1	-1.98	-3.28
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	12.32	17.89	9.42	4.96	99.17
Gross Profit, 1 Yr. Growth %	15.84	13.89	7.81	2.16	32.77
EBITDA, 1 Yr. Growth %	32.89	26.38	-20.63	19.6	-13.6
EBITA, 1 Yr. Growth %	31.96	27.52	-18.68	18.53	-8.62
EBIT, 1 Yr. Growth %	31.96	27.52	-18.68	18.53	-8.62
Earnings From Cont. Operations, 1 Yr. Growth %	13.62	19.13	-18.76	44.84	-10.5
Net Income, 1 Yr. Growth %	13.62	19.13	-18.76	44.78	-10.78
Normalized Net Income, 1 Yr. Growth %	24.12	19.11	-16.34	23.98	-0.4
Diluted EPS Before Extra, 1 Yr. Growth %	-16.01	12.83	-23.74	30.75	-57.07
Accounts Receivable, 1 Yr. Growth %	9.4	52.76	10.3	41.19	-29.15
Inventory, 1 Yr. Growth %	76.42	35.59	-9.06	-47.51	1.86
Net Property, Plant and Equip., 1 Yr. Growth %	23.05	4.19	-10.08	597.09	-15.93
Total Assets, 1 Yr. Growth %	79.54	-17.23	-0.9	21.65	0.46
Tangible Book Value, 1 Yr. Growth %	250.62	-35.34	-43.9	-136.46	84.68
Common Equity, 1 Yr. Growth %	234.11	-33.01	-40.08	-18.96	-19.23
Cash From Operations, 1 Yr. Growth %	-1.43	9.85	4.23	-3.25	-34.27
Capital Expenditures, 1 Yr. Growth %	222.33	38.93	-27.53	-38.12	-45.36
Levered Free Cash Flow, 1 Yr. Growth %	-6.4	25.45	-1.21	-13.3	-40.88
Unlevered Free Cash Flow, 1 Yr. Growth %	-5.47	29.1	-5.5	-22.84	-60.53
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-6.04	15.07	13.57	7.17	44.59
Gross Profit, 2 Yr. CAGR %	-3.89	14.86	10.81	4.94	16.46
EBITDA, 2 Yr. CAGR %	0.27	24.01	0.16	-2.39	1.66
EBITA, 2 Yr. CAGR %	0.25	24.38	1.78	-1.65	4.07
EBIT, 2 Yr. CAGR %	0.25	24.38	1.78	-1.65	4.07
Earnings From Cont. Operations, 2 Yr. CAGR %	3.63	16.34	-1.62	8.48	13.86
Net Income, 2 Yr. CAGR %	3.63	16.34	-1.62	8.45	13.66
Normalized Net Income, 2 Yr. CAGR %	2.8	17.39	-0.17	2.01	16.68
Diluted EPS Before Extra, 2 Yr. CAGR %	-11.98	-2.65	-7.24	-0.15	-25.08
Accounts Receivable, 2 Yr. CAGR %	15.31	29.27	29.8	24.79	0.02
Inventory, 2 Yr. CAGR %	53.79	54.67	11.05	-30.91	-26.88
Net Property, Plant and Equip., 2 Yr. CAGR %	2.03	13.23	-3.21	150.37	142.09
Total Assets, 2 Yr. CAGR %	18.74	21.9	-9.44	9.8	10.55
Tangible Book Value, 2 Yr. CAGR %	35.12	48.35	-39.77	-54.78	-17.94
Common Equity, 2 Yr. CAGR %	33.42	49.61	-36.64	-30.32	-19.1
Cash From Operations, 2 Yr. CAGR %	-4.19	4.05	7	0.42	-20.25
Capital Expenditures, 2 Yr. CAGR %	70.12	111.61	0.34	-33.03	-41.85
Levered Free Cash Flow, 2 Yr. CAGR %	0.2	4.97	11.28	-7.31	-28.4
Unlevered Free Cash Flow, 2 Yr. CAGR %	-0.53	6.37	10.37	-14.45	-44.82
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	1.58	1.34	13.16	10.63	31.76
Gross Profit, 3 Yr. CAGR %	2.68	1.7	12.46	7.84	13.5
EBITDA, 3 Yr. CAGR %	11.12	8.31	7.62	6.39	-6.28
EBITA, 3 Yr. CAGR %	10.92	8.62	8.57	7.21	-4.03
EBIT, 3 Yr. CAGR %	10.92	8.62	8.57	7.21	-4.03
Earnings From Cont. Operations, 3 Yr. CAGR %	8.98	8.56	3.22	11.92	1.74
Net Income, 3 Yr. CAGR %	8.98	8.56	3.22	11.9	1.62
Normalized Net Income, 3 Yr. CAGR %	8.4	7.97	5.43	7.42	1.2
Diluted EPS Before Extra, 3 Yr. CAGR %	-23.11	-4.38	-10.26	4	-24.64
Accounts Receivable, 3 Yr. CAGR %	20.79	26.64	22.61	33.49	3.34
Inventory, 3 Yr. CAGR %	39.22	47.47	29.58	-13.5	-21.37
Net Property, Plant and Equip., 3 Yr. CAGR %	54.72	2.75	4.86	86.92	74.02
Total Assets, 3 Yr. CAGR %	6.47	5.28	13.77	-0.08	6.59
Tangible Book Value, 3 Yr. CAGR %	6.74	4.65	7.28	-49.05	-27.71
Common Equity, 3 Yr. CAGR %	6.23	6.04	10.28	-31.23	-26.8
Cash From Operations, 3 Yr. CAGR %	10.77	0.28	4.11	3.47	-12.81
Capital Expenditures, 3 Yr. CAGR %	32.52	59.02	48.05	-14.59	-37.42
Levered Free Cash Flow, 3 Yr. CAGR %	5.78	8	3.5	2.5	-20.21
Unlevered Free Cash Flow, 3 Yr. CAGR %	6.34	8.5	2.99	-1.92	-33.9
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	10.07	10.03	6.22	3.63	24.81
Gross Profit, 5 Yr. CAGR %	9.6	10.05	5.86	2.99	14.04
EBITDA, 5 Yr. CAGR %	24.58	20.36	7.05	4.34	5.28
EBITA, 5 Yr. CAGR %	23.72	20.46	7.56	4.75	6.83
EBIT, 5 Yr. CAGR %	23.72	20.46	7.56	4.75	6.83
Earnings From Cont. Operations, 5 Yr. CAGR %	22.66	18.27	4.61	8.53	7.35
Net Income, 5 Yr. CAGR %	22.66	18.27	4.61	8.52	7.27
Normalized Net Income, 5 Yr. CAGR %	22.26	17.88	5.23	5.89	7.74
Diluted EPS Before Extra, 5 Yr. CAGR %	-56.31	-56.27	-17.12	-2.71	-16.51
Accounts Receivable, 5 Yr. CAGR %	22.59	28.81	24.32	25.9	13.02
Inventory, 5 Yr. CAGR %	31.08	29.24	27.18	8.89	3.07
Net Property, Plant and Equip., 5 Yr. CAGR %	25.68	31.37	28.25	46.72	46.54
Total Assets, 5 Yr. CAGR %	41.61	24.59	-0.2	7.06	12.47
Tangible Book Value, 5 Yr. CAGR %	-13.62	-22.65	-15.6	-25.19	-3.63
Common Equity, 5 Yr. CAGR %	-13.62	-21.6	-13.61	-10.35	-2.57
Cash From Operations, 5 Yr. CAGR %	26.79	22.5	9.24	0.34	-6.42
Capital Expenditures, 5 Yr. CAGR %	48.67	40.65	18.57	12.51	1.87
Levered Free Cash Flow, 5 Yr. CAGR %	-	18.55	8.36	1.97	-10.63
Unlevered Free Cash Flow, 5 Yr. CAGR %	-	20.63	8.43	-0.92	-19.7